ArticleScientific reports2026
Breast imaging with ultra-low field MRI.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Feasibility of Ultra-Low-Field MRI for Breast Imaging.Radiology. Imaging cancer · 2026Article
- miniMORPH: A Morphometry Pipeline for Low-Field MRI in Infants.Human brain mapping · 2026Article
- Ultra-low fieldCommunications chemistry · 2026Article
Corrections and comments
- Update of
Authors and funding
12 authors.
Funding
Abstract
Breast cancer screening is essential for reducing mortality, yet current modalities face significant barriers, including high costs, limited accessibly, and reliance on ionizing radiation, which leads many women to forego regular screenings. Magnetic resonance imaging (MRI) offers a radiation-free alternative, but its adoption for screening is constrained by cost, availability, and the need for IV contrast administration. In this study, we demonstrate the feasibility of ultra-low field (ULF) unilateral breast MRI for screening applications. ULF MRI was performed on 11 healthy women in a prone position. These participants were healthy women without a history of breast cancer. Three breast radiologists could reliably delineate breast outlines and distinguish fibroglandular tissue (FGT) from adipose tissue. Tissue patterns (fatty, scattered, heterogeneous, and extreme FGT) were consistently identified. In two additional patients with prior breast cancer, ULF MRI effectively eliminated magnetic susceptibility artifacts from surgical biopsy clips and in one of these patients revealed post-surgical changes following lumpectomy. Additionally, in another patient, a > 3 cm cyst, previously confirmed on standard clinical ultrasound, was feasible to visualize with ULF MRI. These findings establish the technical feasibility of ULF breast MRI. While preliminary, they motivate further technical development and evaluation to clarify its capabilities and limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.